首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >p38 and c-Jun N-terminal kinase mitogen-activated protein kinase signaling pathways play distinct roles in the response of organogenesis-stage embryos to a teratogen.
【24h】

p38 and c-Jun N-terminal kinase mitogen-activated protein kinase signaling pathways play distinct roles in the response of organogenesis-stage embryos to a teratogen.

机译:p38和c-Jun N端激酶有丝分裂原激活的蛋白激酶信号转导通路在器官形成阶段胚胎对致畸物的应答中起着不同的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Mitogen-activated protein kinase (MAPK) signaling plays an important role during embryo development. We hypothesize that MAPK activation is a determinant of the fate of organogenesis-stage embryos exposed to insult. To test this hypothesis, CD1 mice were exposed to a model teratogen, hydroxyurea, on gestational day 9. Hydroxyurea exposure triggered a dramatic, transient increase in the activation of p38 MAPKs and c-Jun N-terminal kinases (JNKs) in embryos, without activating extracellular signal-regulated kinases 1 and 2. Selectively blocking p38 MAPKs with 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole (SB203580) enhanced hydroxyurea-induced fetal mortality without affecting growth retardation or the incidence of deformities among surviving fetuses. In contrast, selectively blocking JNKs with JNK peptide inhibitor 1, L-stereoisomer did not affect hydroxyurea-induced fetal death but increased the incidence of the hindlimb defects observed. Thus, p38 MAPKs and JNKs play distinctroles in protecting the conceptus against insult. Pharmacological inhibition of teratogen exposure induced MAPK activation has adverse consequences on the embryo.
机译:丝裂原激活的蛋白激酶(MAPK)信号在胚胎发育过程中起着重要作用。我们假设,MAPK激活是受侮辱的器官发生阶段胚胎命运的决定因素。为了验证这一假设,在妊娠第9天,将CD1小鼠暴露于模型致畸剂羟基脲中。羟基脲引发了胚胎中p38 MAPK和c-Jun N端激酶(JNK)活化的急剧而短暂的增加。激活细胞外信号调节激酶1和2。用4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)1H-咪唑(SB203580)选择性阻断p38 MAPKs增强了羟基脲诱导的胎儿死亡率而不会影响存活胎儿的发育迟缓或畸形的发生。相反,用JNK肽抑制剂1选择性阻断JNKs,L-立体异构体不会影响羟基脲诱导的胎儿死亡,但会增加观察到的后肢缺陷的发生率。因此,p38 MAPK和JNK在保护概念免受侵害中起着不同的作用。致畸剂暴露引起的MAPK活化的药理抑制作用对胚胎有不利影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号